We support boolean queries, use +,-,<,>,~,* to alter the weighting of terms
Software for a genome wide mapping data interpretation platform for NGS (ChIPSeq).
Software tool for base and quality calling of trace files from DNA sequencing instruments.
An open source package for primary data analysis on next-gen sequence data from images to basecalls. Currently Swift is targeted toward Solexa/Illumina sequencing, but is designed to be platform agnostic.
Software that provides probabilistic base calling, quality checks and diagnostic plots for Solexa sequencing data.
Software that identifies protein binding sites from ChIP-seq and nucleosome positioning experiments.
The Division of Biology and Biomedical Sciences at Washington University in St. Louis offers exceptional doctoral training at one of the nations preeminent biomedical research centers. The Division consists of 12 doctoral training programs, 10 of which are ranked among the nations top 10.* :A collaborative, interdisciplinary approach to research and education is a hallmark of Washington University and the Division. As a university-wide consortium, the Division transcends departmental lines and removes traditional boundaries of scientific fields. Faculty and graduate students regularly cross disciplines, devising novel questions and approaches that might otherwise go unexplored. The Division currently consists of 685 graduate students and 410 faculty members from 32 university-wide departments..
THIS RESOURCE IS NO LONGER IN SERVICE,documented on August 16, 2019. Fugu genome is among the smallest vertebrate genomes and has proved to be a valuable reference genome for identifying genes and other functional elements such as regulatory elements in the human and other vertebrate genomes, and for understanding the structure and evolution of vertebrate genomes. This site presents version 4 of the Fugu genome, released in October 2004 by the International Fugu Genome Consortium. Fugu rubripes has a very compact genome, with less than 15 consisting of dispersed repetitive sequence, which makes it ideal for gene discovery. A draft sequence of the fugu genome was determined by the International Fugu Genome Consortium in 2002 using the ''whole-genome shotgun'' sequencing strategy. Fugu is the second vertebrate genome to be sequenced, the first being the human genome. This webpage presents the annotation made on the fourth assembly by the IMCB team using the Ensembl annotation pipeline. We are continuing with the gap filling work and linking of the scaffolds to obtain super-contigs.
The information in this manual is presented to assist health care professionals caring for cancer patients undergoing treatment with cytotoxics, hormones or biological response modifiers. It is designed primarily for pharmacists and nurses in general practice, and may also be of interest to the family physician who is treating a patient in consultation with an oncologist. Efforts have been made to include information specific to the use of these drugs in the child with cancer. Because of the nature of individual drug monographs, this manual does not deal with therapeutics. For treatment decisions, the reader is referred to the protocol by which the patient is being treated, to the British Columbia Cancer Agency''s Cancer Management Manual and to the most current literature. The Cancer Drug Manual also provides a drug index for physicians and patients. The BC Cancer Agency, an agency of the Provincial Health Services Authority, provides a province-wide, population-based cancer control program for the residents of British Columbia and the Yukon. The BC Cancer Agencys mandate covers the spectrum of cancer care, from prevention and screening, to diagnosis, treatment, and through to rehabilitation. The BC Cancer Agencys mandate is driven by a three-fold mission: -To reduce the incidence of cancer -To reduce the mortality rate of people with cancer -To improve the quality of life of people living with cancer
A microsatellite database of commercially important fishes and shellfishes of the Indian subcontinent.
Software package that is an implementation of the BayesPeak algorithm for peak-calling in ChIP-seq data.
This collection of tools stream-lines the processing of HiC data from raw sequence to contact matrices and beyond.
A bioinformatics tool for error correction of HTS read data.
The CIRRIE Database of International Rehabilitation Research currently contains almost 90,000 citations of international rehabilitation research published between 1990 and the present. The CIRRIE Database collects citations from all areas of rehabilitation and compiles them into one central source. In addition to indexing from mainstream journals and internet sites, CIRRIE also includes citations to resources not readily available to U.S. researchers. Over 5000 journals are represented in the Database and abstracts are available for most citations. A list of journals is now available. There are almost 90,000 citations currently indexed with citations added monthly. The database includes citations from 1990 to the present. It was created to facilitate the sharing of information and expertise in rehabilitation and disability research between the U.S. and other countries.
A parallel multistage k-hopo spectrum based homopolymer-length error corrector for 454 sequencing data.
A database of ingredients in brand-name household products linked to health information from Material Safety Data Sheets (MSDS) provided by manufacturers. The database is designed to help answer the following typical questions: *What are the chemical ingredients and their percentage in specific brands? *Which products contain specific chemical ingredients? *Who manufactures a specific brand? How do I contact this manufacturer? *What are the acute and chronic effects of chemical ingredients in a specific brand? *What other information is available about chemicals in the toxicology-related databases of the National Library of Medicine? NLM and its Contractor (the Database Providers) do not test products nor investigate to determine if this information is complete or accurate.
IRIS is a toxicology data file on the National Library of Medicine''s (NLM) Toxicology Data Network. It contains data in support of human health risk assessment. It is compiled by the U.S. Environmental Protection Agency (EPA) and contains over 500 chemical records. It is a compilation of electronic reports on specific substances found in the environment and their potential to cause human health effects. IRIS was initially developed for EPA staff in response to a growing demand for consistent information on substances for use in risk assessments, decision-making and regulatory activities. The information in IRIS is intended for those without extensive training in toxicology, but with some knowledge of health sciences. The Integrated Risk Information System (IRIS) is an electronic database containing information on human health effects that may result from exposure to various substances in the environment. IRIS is prepared and maintained by the EPAs National Center for Environmental Assessment (NCEA) within the Office of Research and Development (ORD). The heart of the IRIS system is its collection of searchable documents that describe the health effects of individual substances and that contain descriptive and quantitative information in the following categories: -Noncancer effects: Oral reference doses and inhalation reference concentrations (RfDs and RfCs, respectively) for effects known or assumed to be produced through a nonlinear (possibly threshold) mode of action. In most instances, RfDs and RfCs are developed for the noncarcinogenic effects of substances. -Cancer effects: Descriptors that characterize the weight of evidence for human carcinogenicity, oral slope factors, and oral and inhalation unit risks for carcinogenic effects. Where a nonlinear mode of action is established, RfD and RfC values may be used.
A program to merge paired end Illumina reads that are overlapping into a single longer read.
Material Safety Data Sheets for chemical products are available to laboratory workers for most chemicals and reagents. However because many laboratory workers, whether in research, public health, teaching, etc., are exposed to not only chemicals but infectious substances as well, there was a large gap in the readily available safety literature for employees. These MSDS are produced for personnel working in the life sciences as quick safety reference material relating to infectious micro-organisms. The MSDS are organized to contain health hazard information such as infectious dose, viability (including decontamination), medical information, laboratory hazard, recommended precautions, handling information and spill procedures. The intent of these documents is to provide a safety resource for laboratory personnel working with these infectious substances. Because these workers are usually working in a scientific setting and are potentially exposed to much higher concentrations of these human pathogens than the general public, the terminology in these MSDS is technical and detailed, containing information that is relevant specifically to the laboratory setting. It is hoped along with good laboratory practices, these MSDS will help provide a safer, healthier environment for everyone working with infectious substances. The MSDS is ran by the Public Health Agency of Canada. The Public Health Agency of Canada (PHAC) is the main Government of Canada agency responsible for public health in Canada. PHACs primary goal is to strengthen Canadas capacity to protect and improve the health of Canadians and to help reduce pressures on the health-care system. To do this, the Agency is working to build an effective public health system that enables Canadians to achieve better health and well-being in their daily lives by promoting good health, helping prevent and control chronic diseases and injury, and protecting Canadians from infectious diseases and other threats to their health. PHAC is also committed to reducing health disparities between the most advantaged and disadvantaged Canadians. Because public health is a shared responsibility, the Public Health Agency of Canada works in close collaboration with all levels of government (provincial, territorial and municipal) to build on each others skills and strengths. The Agency also works closely with non-government organizations, including civil society and business, and other countries and international organizations like the World Health Organization (WHO) to share knowledge, expertise and experiences.
Provides an efficient tool for trimming adapter sequences and low quality sequences, in raw reads generated by the high throughput sequencing platforms.
Flexible barcode and adapter removal for sequencing platforms.